| Description | Naptumomab, a tumor-targeting superantigen (TTS), is a fusion protein that activates the immune system to recognize and eradicate tumor cells. It shows promise in researching refractory solid tumors, including renal cell carcinoma [1] [2]. |
| molecular weight | N/A |
| CAS | 1412892-09-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |